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ABSTRACT
Objectives To investigate authors’ awareness and use of 
authorship guidelines, and to assess their perceptions of 
the fairness of authorship decisions.
Design A cross- sectional online survey.
Setting and participants Corresponding authors of 
research papers submitted in 2014 to 18 BMJ journals.
Results 3859/12 646 (31%) researchers responded. They 
worked in 93 countries and varied in research experience. 
Of these, 1326 (34%) reported their institution had an 
authorship policy providing criteria for authorship; 2871 
(74%) were ‘very familiar’ with the International Committee 
of Medical Journal Editors’ authorship criteria and 3358 
(87%) reported that guidelines were beneficial when 
preparing manuscripts. Furthermore, 2609 (68%) reported 
that their use was ‘sometimes’ or ‘frequently’ encouraged 
in their research setting. However, 2859 respondents 
(74%) reported that they had been involved in a study at 
least once where someone was added as an author who 
had not contributed substantially (honorary authorship), 
and 1305 (34%) where someone was not listed as an 
author but had contributed substantially (ghost authorship). 
Only 740 (19%) reported that they had never experienced 
either honorary or ghost authorship; 1115 (29%) reported 
that they had experienced both at least once. There was no 
clear pattern in experience of authorship misappropriation 
by continent. For their last coauthored article, 2187 (57%) 
reported that explicit authorship criteria had been used to 
determine eligibility, and 3088 (80%) felt that the decision 
made was fair. When institutions frequently encouraged 
use of authorship guidelines, authorship eligibility was 
more likely to be discussed early (817 of 1410, 58%) and 
perceived as fairer (1273 of 1410, 90%) compared with 
infrequent encouragement (974 of 2449, 40%, and 1891 
of 2449, 74%).
Conclusions Despite a high level of awareness of 
authorship guidelines and criteria, these are not so 
widely used; more explicit encouragement of their use by 
institutions may result in more favourable use of guidelines 
by authors.
INTRODUCTION
The research process, including publica-
tion, is based on trust. Authorship is both 
about being credited for the work you have 
done and being responsible and account-
able for the integrity of what is published.1–3 
Responsible authorship is a key compo-
nent of publication ethics and transparent 
reporting.4 Infringing the rules of authorship 
in scientific papers can negatively impact 
on the credibility of the findings as well as 
on the honesty of the authors. However, the 
temptation for scientists to abuse authorship 
is significant since their publication record 
and collaboration with coauthors can deter-
mine academic rewards such as medical qual-
ifications and professional appointments, as 
well as research funding.5 Studies reviewing 
published papers have identified a high prev-
alence of authorship problems.6–9
The average number of authors per 
published article has grown over time10 11 
and this has raised questions around author-
ship in terms of eligibility, definition of their 
roles and establishment of a fair sequence 
of authors’ names according to their role.12 
Decisions about authorship eligibility can be 
subjective and contentious, since an author 
could contribute to the research without 
being involved in the actual writing, for 
example, by collecting data or conducting the 
statistical analysis. There is a huge variation 
in the operational definition of authorship4 
and preference for authorship order varies 
by country and discipline.12–14 In biomedi-
cine, it is generally assumed that individuals 
are listed in decreasing order of level of their 
contribution with the exception of the last 
Strengths and limitations of this study
 ► Very large international survey of active researchers 
describing their current practice.
 ► We address authorship practice, which is an im-
portant ethical matter because authorship ensures 
credit and accountability for research.
 ► We report self- administered survey data, and given 
the sensitivity of the questions, social desirability 
bias may have led respondents to over- report their 
awareness and usage of authorship guidelines.
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and the corresponding authors to whom importance is 
also attached.15 In other disciplines such as psychology, 
it is the first author who assumes responsibility for the 
publication and handles responses to inquiries after 
publication and coauthors are listed in order of level of 
contribution.
While authorship eligibility and order can reflect 
legitimate regional or discipline- specific practices, some 
scientists also intentionally misappropriate authorship. 
Honorary authors are those who did not contribute 
substantially to the conception or design of the work; 
or the acquisition, analysis or interpretation of the 
data for the work; or the writing of the article; and 
are unable to take public responsibility for the work.16 
Honorary authorship may occur as a result of many 
factors, including nepotism; reciprocation of favours for 
previous authorships; institutional politics and power 
struggles; economic reasons to justify obtained grants 
or demands for new funding and trying to improve the 
chance of manuscript acceptance by including senior 
researchers.4 9 Ghost authors are those who are not listed 
as authors despite contributing substantially in these 
areas.16 Ghost authorship is especially undesirable when 
it masks the involvement of a commercial sponsor or 
other competing interests that could bias the study or 
reporting.17 Both honorary and ghost authorships are 
considered forms of research misconduct. Estimates from 
author surveys of the prevalence of honorary authors in 
high impact biomedical journals during the last 30 years 
have ranged from 19% to 39%7 16 18 and ghost authors 
from 8% to 11%.7 16 18
To help scientists define authorship and limit miscon-
duct, multiple guidelines have been produced and jour-
nals have introduced various measures to try to encourage 
ethical authorship practice.19 The International 
Committee of Medical Journal Editors (ICMJE) criteria, 
adopted by many international biomedical journals and 
generally considered the ‘gold standard’ for determining 
authorship eligibility, enumerate specific requirements 
for authorship, as well as stipulating that all authors 
should participate sufficiently in the work reported in 
an article to be able to take public responsibility for the 
content or an important part of the content.20 While many 
journals continue to encourage the use of ICMJE criteria, 
previous studies of selected samples of researchers have 
shown poor awareness of them,21 22 dislike of them,22 23 
failure to comply with them6 and preference for other 
authorship policies and practices.24 One critic has even 
described them as illogical and unethical.25 Some jour-
nals have introduced their own authorship criteria.26 
Others have shown that ICMJE criteria are intuitive and 
that the ICMJE- listed contributions are perceived as 
important.27 28 However, there are no uniform rules for 
authorship order.14 We describe a large international 
survey undertaken to determine awareness and use of 
authorship guidelines and criteria in a contemporary 




We developed a 12- item online closed questionnaire (see 
online supplemental appendix 1) with five additional 
demographic questions and a free- text item for addi-
tional comments. We piloted the questionnaire with 16 
researchers to check for ambiguous items and revised the 
questionnaire in light of feedback. The final question-
naire included items addressing familiarity with and use 
of authorship criteria, experience of authorship misap-
propriation, frequency and timing of authorship discus-
sions, perceived fairness of authorship decisions and 
institutional encouragement to use authorship criteria.
Sample
We included authors submitting research articles in 2014 
to 18 journals covering a range of specialties published 
by BMJ Publishing Group (see online supplemental 
appendix 2). To try to get a broad sample of biomed-
ical journals of varying size and prestige, we intention-
ally selected journals with high, middle and low impact 
factors (IFs). As a deviation from our protocol, we also 
sampled some recently acquired journals with no IF. All 
journals adhered to the ICMJE guidelines by asking corre-
sponding authors to assure that they are respected.
Procedures
All corresponding authors of accepted and rejected 
research manuscripts submitted in 2014 were identified 
from each of the journal’s manuscript tracking systems, 
and the data merged. Duplicate authors were removed 
so that each author was invited to take part in the survey 
only once. We selected one journal to act as a pilot to 
gauge response rate and invited eligible authors of 
this journal by an email on 14 March 2016 from SS, an 
employee of BMJ Publishing Group, to complete the 
survey hosted by SurveyMonkey; eligible authors of the 
other 17 journals were invited on 14 September 2016. 
Authors were informed that participation was voluntary 
and that responses would be anonymised and treated 
confidentially. Participants were not asked to give consent 
to take part; they were informed that completion of the 
survey would indicate that they had consented to take 
part. Non- responders were sent reminders at 2 weeks and 
4 weeks after the initial mailing and the survey was open 
for completion for a 6- week period. To try to maximise 
recruitment, we gave an incentive of the chance to win a 
prize draw for a £100 voucher.
Patient and public involvement
We did not involve patients in the research team or devel-
opment of the questionnaire as the focus was on academic 
researchers’ perceptions and their institutional experi-
ences. We recognise that patients are sometimes authors 
and may have different experiences as authors, but this 
forms only a small proportion of the published literature 
and patients’ experience as authors was not the intended 
focus of the paper. To adequately capture patients’ 
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experience of authorship would require a different set of 
questions.
Statistical analysis
Responses from all journals were collated and the anony-
mised combined sample analysed using SPSS V.18. 




Of the 12 658 email invitations sent, 259 were not delivered 
by SurveyMonkey, 17 generated automated responses that 
recipients were on long- term leave or had retired and 3 
recipients indicated they had been invited via a different 
email address. We received an actual response from 3859 
(31%) of the remaining 12 379 authors. Response rates 
by journal ranged between 20% and 41%. All results 
are presented as the number or proportion of all 3859 
respondents unless explicitly stated otherwise.
Table 1 shows the characteristics of the sample. The 
majority of authors had submitted a paper that had 
been rejected by the sampled journal in 2014. A higher 
proportion of respondents were male (56%) than female 
(41%) and the majority (71%) were based in a univer-
sity setting. Respondents varied in research and publi-
cation experience and worked in 93 countries, with the 
highest proportions based in the UK (20%), USA (10%), 
Australia (6%) and the Netherlands (5%). Overall, the 
majority of respondents were based in Europe (54%).
Familiarity with and use of authorship criteria
After being presented with the ICMJE criteria, 258 (7%) 
reported that they had never heard of them, 706 (18%) 
had heard of them but were not familiar with their 
content and 2871 (74%) were very familiar with them. 
Of those who were very familiar with ICMJE criteria, 90% 
(2572/2871) reported that authorship guidelines and 
criteria were beneficial to research teams when preparing 
papers and deciding on authorship.
In relation to the last paper they coauthored, 2187/3859 
(57%) reported that explicit authorship criteria were used 
to decide who should be an author, 1284/3859 (33%) 
said that they did not use them and 296/3859 (8%) did 
not know. Only 1827 (64%) of the 2871 who were very 
familiar with ICMJE criteria reported that explicit author-
ship criteria were used to decide who should be an author 
in their last coauthored paper.
Authorship misappropriation
Only around a quarter of researchers (929/3859) 
reported that they had never been involved in a study 
where someone was added as an author who did not 
contribute substantially (honorary authorship) (table 2). 
The frequency of involvement in studies with ghost 
authors was less than for honorary authors with nearly 
two- thirds of authors (2481/3859) never having been 
involved in a study where someone was not listed as an 
author when they had contributed substantially.
Only around a fifth of all respondents (740/3859, 19%) 
reported that they had never experienced either guest or 
ghost authorship, whereas nearly a third (1115/3859, 
29%) reported that they had experienced both at least 
once in their careers. Researchers who had been active 
for more than 10 years reported a higher frequency of 
experience of authorship misappropriation than those 
who had been active for less than 10 years. Respondents 
who reported their institution had an authorship policy 
Table 1 Respondent characteristics (n=3859)
n %
Editorial decision made on submitted article
  Accept 839 22
  Reject 3020 78
Gender
  Male 2150 56
  Female 1585 41
Institution of work
  University setting 2739 71
  Public research centre 511 13
  Private research centre 113 3
  Industry 29 1
  Other 349 9
Number of years as an active researcher
  <5 years 846 22
  6–10 years 1021 27
  11–15 years 628 16
  16–20 years 462 12
  More than 20 years 772 20
Number of papers published
  ≤5 509 13
  6–10 478 12
  11–20 521 14
  21–30 416 11
  31–40 274 7
  41–50 229 6
  51–100 592 15
  >100 689 18
Continent
  Africa 79 2
  Asia 652 17
  Europe 2073 54
  North America 594 15
  South America 90 2
  Oceania 243 6
Percentages do not sum to 100% due to missing data.
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were more likely (374/1326, 28%) to have never been 
involved in a study with honorary authorship than those 
who reported their institution did not have an authorship 
policy (301/1592, 19%). We found no clear pattern of 
perceived authorship misappropriation by continent (see 
online supplemental appendix 3).
Timing of authorship discussions
Authorship eligibility and authorship order were 
discussed at an early stage more often when institutions 
had authorship policies, when authors were very familiar 
with ICMJE criteria, when institutions encouraged use 
of authorship guidelines frequently and when explicit 
authorship criteria were used to decide who should be 
an author, compared with not (see online supplemental 
appendices 4 and 5).
Authorship eligibility was discussed at both an early 
stage and during the course of the study for a small 
proportion of recently coauthored articles and author-
ship order was discussed at both these points even less 
frequently, even when authorship institutional policies 
were in place.
Perceived fairness of authorship decisions
In relation to the last paper they coauthored, 80% 
(3088/3859) of respondents felt that the decision on who 
was made an author was fair (486, 13% not fair) and 82% 
(3157) felt that the decision on authorship order was fair 
(409, 11% not fair). When explicit criteria were used in 
authorship decisions, a higher proportion reported that 
the decision made on authorship eligibility (2043/2187, 
93%) and authorship order (2015/2187, 92%) was fair, 
compared with when they were not used (879/1284, 69%) 
and (946/1284, 74%), respectively, as shown in online 
supplemental appendix 6. More experienced researchers 
and those working in settings where the use of criteria was 
actively encouraged reported higher rates of fairness for 
authorship decisions on their last coauthored paper than 
less experienced researchers and those working in settings 
where the use of criteria was not actively encouraged.
Institutional policy
Only 34% (1326/3859) of respondents reported that 
their institution had an authorship policy; 41% (1592) 
said that there was no such policy and 24% (919) said 
that they did not know. For institutions with an author-
ship policy, 724/1326 (55%) frequently encouraged 
researchers to use it and 434/1326 (33%) sometimes.
Overall, when institutions frequently encouraged the 
use of authorship guidelines, decisions were more likely 
to be discussed at an early stage, were perceived as fairer 
and incidences of honorary and ghost authorships were 
reported as less common compared with when frequent 
institutional encouragement was not reported (infre-
quent, no encouragement, not sure and other) (table 3).
DISCUSSION
Our large survey of nearly 4000 active researchers from 
93 countries found that almost three- quarters were very 
familiar with the ICMJE authorship criteria and a higher 
proportion viewed these and other authorship guidelines 
as beneficial. Around two- thirds reported that their insti-
tution frequently or sometimes encouraged the use of 
these or similar authorship criteria. Yet, only just over half 
used explicit authorship criteria when deciding on author-
ship for their last coauthored paper. When institutions 
frequently encouraged the use of authorship guidelines, 
authorship eligibility was more likely to be discussed early 
and was perceived as fairer. Reported incidences of author-
ship misappropriation over the course of researchers’ 
careers were high; around three- quarters of respondents 
had experienced honorary authorship and one- third ghost 
authorship. Respondents self- reported multiple barriers to 
using authorship criteria in practice.
Comparison with other studies
Our results build on the results of earlier surveys7 16 18 
by providing a snapshot of authorship practice from a 
very large international sample of active researchers in a 
broad range of biomedical specialties. Similar to previous 
studies,7 16 18 we found reported rates of honorary 
Table 2 Experience of authorship misappropriation by years of research experience










































Never 929 (24) 250 (30) 498 (27) 404 (22) 2481 (64) 604 (71) 1288 (69) 1152 (62)
Once 427 (11) 168 (20) 283 (15) 134 (7) 415 (11) 99 (12) 209 (11) 197 (11)
A few times 1911 (50) 337 (40) 853 (46) 1032 (55) 823 (21) 129 (15) 341 (18) 466 (25)
A lot of times 521 (14) 90 (11) 229 (12) 287 (15) 67 (2) 12 (1) 26 (1) 41 (2)
Percentages do not sum to 100% due to missing data.
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authorship were higher than for ghost authorship. The 
proportion who had experienced honorary and ghost 
authorships was higher than previous surveys conducted 
between 1998 and 2011,7 18 but our respondents were 
asked about experience across their careers rather than 
about a specific publication and we did not just include 
high impact journals. We found no clear pattern of 
perceived authorship misappropriation by continent, 
which is in contrast to the findings of a systematic review 
in 2011, which found authorship problems and misuse 
were reported more often by researchers outside of the 
USA and the UK.9
Researchers in our study reported a higher level of 
familiarity and use of authorship guidelines and criteria 
than previous studies.21 22 This may partly be explained 
by wider promotion of these criteria and changes in 
authorship practice over time. For example, in some 
Nordic countries, compulsory courses on authorship 
guidelines have been introduced from the first year of 
the PhD programme. Early researchers are trained to 
discuss with their supervisor how to establish an equitable 
authorship order for papers. We may also have observed 
a higher level of familiarity and use of authorship guide-
lines because our sample was larger and composed of 
corresponding authors of articles submitted to journals 
promoting ICMJE criteria and requesting compliance 
with these criteria prior to publication.
However, despite such familiarity, more than one- third of 
our sample declared that explicit authorship criteria were 
not used to decide who should be an author on their most 
recent article. Similarly, Bonekamp et al24 found a high rate 
of awareness (81%) of ICMJE criteria among submitting 
authors, yet 25% reported that at least one of their coau-
thors on the submission did not merit authorship. Our 
respondents described the difficulties of applying author-
ship criteria when, for example, colleagues disregard them, 
there are power imbalances and a strong cultural norm 
to attribute authorship in certain ways. Research culture 
is increasingly characterised by unhealthy competition, 
job insecurity, poor supervision and mentorship, discrim-
ination, bullying and harassment,29 which can only have 
a negative impact on the quality of research and compli-
ance with authorship guidelines and criteria. Early career 
researchers in particular can be pressured by supervisors 
to produce more research papers in journals with high 
IFs. The inclusion of senior researchers as coauthors, irre-
spective of their contribution, can increase the chances of 
publication in a competitive field. In addition, honorary 
authorship can give coauthors opportunities to strengthen 
collaborations with other researchers and increase the visi-
bility of their work.
Study limitations
Our study has several limitations. First, we received a low 
(31%) response rate, which may have caused selection 
bias. However, response rates to surveys of doctors and 
researchers are often low.30–33 Only a fifth of invited authors 
had their papers accepted by the journals in the sampling 
period and this may have affected their willingness to help. 
Also, some authors informed us that they only received 
Table 3 Stratification of responses by whether the use of explicit authorship guidelines and criteria in current research setting 
is frequently encouraged or not
n (%)








Agrees that the explicit use of authorship guidelines and criteria is beneficial 
to research teams when preparing a paper and deciding on authorship
1330 (94) 2025 (84)
Never been involved in a study where someone has been added as an author 
who did not contribute substantially (honorary authorship)
426 (30) 501 (21)
Never been involved in a study where someone was not listed as an author 
when they contributed substantially (ghost authorship)
951 (67) 1526 (64)
Never experienced honorary or ghost authorship 350 (25) 388 (16)
Experienced both honorary and ghost authorships 370 (26) 744 (31)
Authorship eligibility discussed at an early stage during study design 817 (58) 970 (40)
Authorship order discussed at an early stage during study design 497 (35) 566 (24)
Used explicit authorship criteria to decide who should be an author on their 
last coauthored paper
1161 (82) 1023 (43)
Felt decision on who should be an author on their last coauthored paper was 
a fair reflection of who did what
1273 (90) 1810 (75)
Felt decision on order of authorship on their last coauthored paper was a fair 
reflection of who did what
1266 (90) 1886 (79)
*Includes responses of ‘other’, ‘not sure’, ‘not encouraged’ and ‘sometimes encouraged’.
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the last reminder email, suggesting that some institutional 
email filters were treating the emails as spam. Despite the 
low response rate, we did receive nearly 4000 responses 
from all continents, which is a substantial survey sample.
Second, however, by surveying submitting authors and 
not just those who had papers accepted for publication 
at the participating journals, we sought to capture the 
experience of researchers from numerous countries 
and of varying levels of research and publication expe-
rience; some respondents will have never published with 
BMJ Publishing Group before. We also sampled authors 
submitting to a range of journals in different specialties 
and with a range of IFs.
Third, analyses are based on self- reported data from 
corresponding authors. We assured participants of confi-
dentiality, but the survey was not anonymous and given 
the sensitivity of the questions, we cannot rule out social 
desirability bias with respondents over- reporting their 
awareness and usage of authorship criteria. We chose to 
contact corresponding authors as they coordinate the 
activities of other authors and are the people most likely 
to have knowledge of the roles and contributions of other 
authors.16
Finally, respondents completed the survey in 2016 and 
as such responses might not accurately reflect the current 
research ecosystem, which is continuously evolving in 
terms of publication policies and strategies.
Study implications
Understanding authorship practice is an important 
ethical matter because appropriate authorship ensures 
credit and accountability for research. Ethical authorship 
practice is essential for the promotion and maintenance 
of the scientific integrity of biomedical research. We 
found that authorship guidelines and criteria are known 
by the majority of researchers and their application is 
considered beneficial when preparing manuscripts. 
However, authorship misconduct is still prevalent; even 
those who are new to research reported experience of it. 
Thus, it is not simply a matter of authors needing to be 
informed about guidelines and criteria, but of having the 
opportunity to apply them in a supportive environment 
that is suited to their discipline.
While both institutions and journals have important 
duties relating to authorship misconduct,19 institutions are 
ultimately responsible for the conduct of their researchers.34 
In 2000, a Task Force on Authorship reporting to the 
Council of Science Editors stated that all universities, 
medical schools, research institutes and commercial 
companies that conduct and publish research should have 
explicit policies on authorship.13 Yet 16 years later, only a 
third of respondents reported that their institution had an 
authorship policy, although this might partly be explained 
by researchers being unaware of existing institutional poli-
cies and the need for better promotion of these. Where 
institutions encouraged the use of authorship guidelines 
and criteria, perceptions of fairness of authorship deci-
sions were higher and discussions on authorship eligibility 
and authorship order were more frequent. Little guidance 
exists on authorship order, which remains one of the major 
issues for most institutions. Institutions should be more 
active in supporting the use of authorship guidelines and 
criteria, especially to support early career researchers and 
to reduce power differentials among authorship teams.15 
Authorship eligibility was discussed at an early stage and 
during the study for only a small proportion of recently 
coauthored articles in our sample. Proponents of good 
authorship practice recommend early discussion of author-
ship in the research process,35 something that could easily 
be encouraged by institutions. While it might be ideal but 
not feasible to have universal criteria for how researchers 
are recognised in publications, having well- designed institu-
tional systems for agreeing and enforcing local and specific 
authorship policies at the start of projects and throughout 
the research process could help in avoiding disputes or 
resolving them quickly.15
On the other side, editors and publishers of some 
biomedical journals are already encouraging the use of 
authorship guidelines. In some journals, when submit-
ting manuscripts, authors must indicate explicitly that all 
authors meet the journal’s criteria for authorship, some 
even request completion of individual authorship confir-
mation forms. Other journals indicate in their instructions 
to authors that papers must meet authorship criteria, but 
do not explicitly enforce this and leave the responsibility 
of respecting these criteria to the authors. Recognising 
the ICMJE criteria may be unworkable in practice, some 
journals have preferred to introduce their own criteria 
for authorship. For example, Neurology recently revised 
its authorship policy, to recognise an author as someone 
who has substantially contributed to one or more of the 
following: design or conceptualisation of the study; major 
role in the acquisition of data; analysis or interpretation of 
the data or drafting or revising the manuscript for intellec-
tual content.26 ICMJE requires authors to fulfil all four of its 
criteria, whereas Neurology requires just one of its criteria 
to be met.
In 1997, recognising the need for systemic reform, 
Rennie et al2 proposed the introduction of published 
contributorship statements whereby individuals are named 
against their specific contributions and individuals can be 
mentioned without being authors on the byline, but most 
journals have not adopted this approach. This is also not 
accepted in most promotion committees for academic 
awards, where the authorship position counts. However, 
CRediT (Contributor Roles Taxonomy)36 has more 
recently been widely adopted by a range of publishers. 
CRediT has 14 different roles within the taxonomy and its 
approach is a step towards more transparency in the defi-
nition of coauthors since the roles of each author need 
to be recognised, categorised and listed when submitting 
to a journal. However, many argue that journal policies 
around authorship criteria lead to a meaningless tick- box 
exercise and studies have shown that published contri-
butions often do not meet ICMJE criteria.8 Much of the 
science is based on trust and journal editors should not 
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adjudicate authorship disputes or police authorship prac-
tice, but they should provide clear advice to authors and 
reviewers and have appropriate policies for editors and 
staff relating to all aspects of publication ethics.34 Journals 
should stipulate that authorship is about accountability as 
well as credit and authorship misappropriation is consid-
ered a form of research misconduct.
While courses in research ethics are now more common, 
many research institutions do not teach courses on publi-
cation ethics and only a small minority of international 
researchers report having substantial knowledge of publi-
cation ethics.37 The Committee on Publication Ethics 
(COPE) was set up to educate and support editors and 
publishers and those involved in publication ethics to foster 
good ethical practice in scientific publication. It provides, 
among others, guidelines to ensure that authorship and 
contributorship are in place, as well as clear policies that 
allow for transparency around who contributed to the work 
and in what capacity. While its members are mainly editors 
and publishers, COPE recently launched a new initiative 
to work in collaboration with several research institutions 
in Australia, Canada and the USA to help address issues 
around publication ethics commonly seen in journals 
further upstream (https:// publicationethics. org/ news/ 
cope- pilot- initiative- institutional- membership). Dealing 
with transgressions in publication ethics at the time of 
publication is often too late, so embedding good research 
practice within research institutions is crucial.
Modifying the ‘microsystem’ of authorship in biomed-
ical research is a challenge that needs to be promptly 
addressed. Some argue that institutions, journal editors and 
funding agencies could introduce more stringent policies 
and punishments around authorship misappropriation.19 
But it is the research culture that we need to change indi-
vidual researchers’ perceptions of moral behaviour. Guide-
lines cannot ensure morally responsible research, especially 
when they are limited to a checklist- like approach instead 
of an ‘abstraction’ level.38 The existence of these guidelines 
can paradoxically lead to a vision of researchers as people 
to distrust since they need a jurisdictional framework 
to practice their profession. Authorship guidelines and 
criteria should not be considered as merely strict rules to 
be respected in a normative way, but a ground for discus-
sion about ethical choices and responsibilities of individual 
authors.
Despite a high level of awareness of authorship guide-
lines and criteria, these are not so widely used. More 
explicit encouragement by institutions to discuss author-
ship early and frequently may result in decisions that are 
perceived as fairer.
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